A Phase III, Multi-centre, Randomized Study to Compare the Efficacy and Safety of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Trial Profile

A Phase III, Multi-centre, Randomized Study to Compare the Efficacy and Safety of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Jan 2018

At a glance

  • Drugs Alalevonadifloxacin (Primary) ; Levonadifloxacin (Primary) ; Linezolid; Linezolid
  • Indications Bacterial infections; Skin infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Wockhardt
  • Most Recent Events

    • 08 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 12 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top